1-(benzyloxy)-4-phenylbutan-2-one | 476470-99-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(benzyloxy)-4-phenylbutan-2-one
• 英文别名: 1-benzyloxy-4-phenyl-2-butanone；1-Benzyloxy-4-phenyl-butan-2-one；4-phenyl-1-phenylmethoxybutan-2-one
• CAS: 476470-99-2
• 化学式: C₁₇H₁₈O₂
• 分子量: 254.329
• InChiKey: WEKFCYVZDNGKJY-UHFFFAOYSA-N

物化性质

• 沸点：
  395.2±22.0 °C(Predicted)
• 密度：
  1.077±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  19
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(benzyloxy)-4-phenylbutan-2-one 在 三乙基硅烷 、 N-羟基-7-氮杂苯并三氮唑 、 TEA 、 三乙基硅基三氟甲磺酸酯 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 (S)-2-Amino-N-(5-benzyl-4-benzyloxymethyl-thiazol-2-yl)-propionamide
  参考文献：
  名称：

  Non-peptidic small molecule inhibitors of XIAP

  摘要：

  Non-peptidic small molecule SMAC mimetics were designed and synthesized that bind to the BIR3 domain of XIAP using structure-based design. Substituted five-membered heterocycles such as thiazoles and imidazoles were identified that serve as replacements for peptide fragments of the lead. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.11.010
• 作为产物：
  描述：

  苄氧乙酸 在 四(三苯基膦)钯 、 草酰氯 、 TEA 、 二甲基亚砜 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 1-(benzyloxy)-4-phenylbutan-2-one
  参考文献：
  名称：

  Non-peptidic small molecule inhibitors of XIAP

  摘要：

  Non-peptidic small molecule SMAC mimetics were designed and synthesized that bind to the BIR3 domain of XIAP using structure-based design. Substituted five-membered heterocycles such as thiazoles and imidazoles were identified that serve as replacements for peptide fragments of the lead. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.11.010

文献信息

• Highly Efficient Synthesis of Terminal Alkenes from Ketones
  作者：Hélène Lebel、Danielle Guay、Valérie Paquet、Kim Huard

  DOI：10.1021/ol049085p

  日期：2004.9.1

  [reaction: see text] The rhodium(I)-catalyzed methylenation of ketones using trimethylsilyldiazomethane proceeds to give the corresponding alkenes in good yields (60-97%). The use of an excess of 2-propanol and 1,4-dioxane as a solvent were instrumental to obtain the desired alkenes in high yields. Superior results were achieved with the rhodium(I)-catalyzed methylenation in comparison with the standard

  [反应：见正文]使用三甲基甲硅烷基重氮甲烷进行铑（I）催化的酮的甲基化反应，得到了相应的烯烃，收率很高（60-97％）。使用过量的2-丙醇和1，4-二恶烷作为溶剂有助于以高收率获得所需的烯烃。与标准Wittig反应相比，铑（I）催化的亚甲基化获得了优异的结果。
• Visible Light Photoredox Cross-Coupling of Acyl Chlorides with Potassium Alkoxymethyltrifluoroborates: Synthesis of α-Alkoxyketones
  作者：Javad Amani、Esmat Sodagar、Gary A. Molander

  DOI：10.1021/acs.orglett.5b03705

  日期：2016.2.19

  A visible-light, single-electron-transfer (SET), photoredox cross-coupling for the synthesis of α-alkoxyketones has been developed. In this method, various aliphatic and aromatic acyl chlorides were successfully coupled with structurally diverse potassium alkoxymethyltrifluoroborates, producing the corresponding α-alkoxyketones with high yields. In this operationally simple and mild cross-coupling

  已经开发了用于合成α-烷氧基酮的可见光，单电子转移（SET），光氧化还原交叉偶联。在这种方法中，成功地将各种脂肪族和芳香族酰氯与结构多样的烷氧基甲基三氟硼酸钾偶联，从而以高收率生产出相应的α-烷氧基酮。在这种操作简单且温和的交叉偶联方案中，所需的酮可通过一种对烷基硼化学和光氧化还原/ Ni催化均具有独特作用的键合连接，从稳定的起始原料中一步获得所需的酮。
• [EN] NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS<br/>[FR] DERIVES DE PYRROLE UTILISES COMME AGENTS PHARMACEUTIQUES
  申请人：LILLY CO ELI

  公开号：WO2002094833A1

  公开（公告）日：2002-11-28

  Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors. The disclosed invention relates to compounds of the structure (I) wherein (I) is a four, five, or six membered saturated ring and X is C, O or S.

  小说吡唑衍生物化合物及其作为药物制剂的用途，特别是作为TGF-beta信号传导抑制剂的用途。所披露的发明涉及结构为（I）的化合物，其中（I）是四、五或六元饱和环，X为C，O或S。
• Novel pyrrole derivatives as pharmaceutical agents
  申请人：——

  公开号：US20040106604A1

  公开（公告）日：2004-06-03

  Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors. The disclosed invention relates to compounds of the structure (I) wherein (I) is a four, five, or six membered saturated ring and X is C, O or S. 1

  小说吡唑衍生物化合物及其作为药物代理的使用，特别是其作为TGF-beta信号转导抑制剂的使用。所公开的发明涉及结构（I）的化合物，其中（I）是四、五或六个成员的饱和环，X是C、O或S。1
• Pyrrole derivatives as pharmaceutical agents
  申请人：Eli Lilly and Company

  公开号：US07087626B2

  公开（公告）日：2006-08-08

  Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors. The disclosed invention relates to compounds of the structure (I) wherein (I) is a four, five, or six membered saturated ring and X is C, O or S

  小说吡唑衍生物化合物及其作为药物代理的用途，特别是它们作为TGF-beta信号转导抑制剂的用途。所披露的发明涉及结构为(I)的化合物，其中(I)是四、五或六成员饱和环，X是C、O或S。